The Impact of Device Modifications and Pressure Delivery on Adherence.


Journal

Sleep medicine clinics
ISSN: 1556-4088
Titre abrégé: Sleep Med Clin
Pays: United States
ID NLM: 101271531

Informations de publication

Date de publication:
Mar 2021
Historique:
entrez: 24 1 2021
pubmed: 25 1 2021
medline: 22 5 2021
Statut: ppublish

Résumé

This article reviews the evidence to date examining whether adherence to positive airway pressure (PAP) therapy is affected by any device modifications to pressure delivery. To date there is no robust evidence from systematic reviews and meta-analyses indicating that any modification to standard fixed-pressure PAP makes a clinically significant difference to patient adherence to therapy. The main modifications are reviewed in this article and whether improving pressure could drive adherence, in turn improving patient outcomes, is discussed.

Identifiants

pubmed: 33485533
pii: S1556-407X(20)30103-X
doi: 10.1016/j.jsmc.2020.10.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-84

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure R. Killick has nothing to declare. N.S. Marshall previously has conducted a trial mentioned in this review, funded by Fisher & Paykel (SensAwake device). He has received in-kind support (investigational product supplied free of charge) from Respironics (now Phillips—the C-Flex modification) for another trial discussed in this review. He also has received in-kind support (investigational product) from Teva (formerly Cephalon) and Neurim for trials outside of the scope of this review, except for 1 trial supported by Teva, which is cited in this review in the context of reestablishing patients on PAP after they have abandoned it.

Auteurs

Roo Killick (R)

Woolcock Institute of Medical Research, The University of Sydney, 431 Glebe Pt Road, Glebe, Sydney, New South Wales 2037, Australia.

Nathaniel S Marshall (NS)

Woolcock Institute of Medical Research, The University of Sydney, 431 Glebe Pt Road, Glebe, Sydney, New South Wales 2037, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: nathaniel.marshall@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH